Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.42 |
| ▸ | LPL | P06858 | 9/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.33 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26683441 | 1.00 | LIPG (0.42) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL24434088 | 0.95 | LIPG (0.46) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL12925749 | 0.95 | LIPG (0.46) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL17700992 | 0.93 | LIPG (0.47) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL23989037 | 0.92 | LIPG (0.40) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL30215959 | 0.92 | LIPG (0.52) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL15714374 | 0.92 | LIPG (0.52) | LIPGLPLALOX5MEN1CYP2C19 | |
| SCHEMBL18287535 | 0.89 | LIPG (0.51) | LIPGLPLENPP3ENPP1CHRNB4 | |
| SCHEMBL24643461 | 0.89 | LIPG (0.44) | LIPGLPLALOX5MEN1KMT2A | |
| SCHEMBL30596099 | 0.88 | LIPG (0.53) | LIPGLPLALOX5MEN1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225733-B1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2024-11-27 | — | — | EP | disclosed |
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-11-23 | — | — | US | disclosed |
| EP-4225733-A2 | COMPOUNDS FOR ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2023-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP2E1, GPX1, ERCC1 | LIPG 2805/4885LPL 4681/4885ALOX5 2648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.